Vaginal Tactile Imaging for Pelvic Floor Prolapse

March 20, 2019 updated by: Artann Laboratories

Vaginal Tactile Imaging in Assessment of Pelvic Floor Conditions

The investigators will analyze biomechanical transformation of pelvic floor tissues and support structures under affected pelvic floor conditions and repaired states after the surgery.

Study Overview

Status

Completed

Intervention / Treatment

Study Type

Observational

Enrollment (Actual)

119

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Florida
      • Tampa, Florida, United States, 33606
        • The Pelvic Floor Institute
    • New Jersey
      • Princeton, New Jersey, United States, 08540
        • Princeton Urogynecology PU
    • Pennsylvania
      • Allentown, Pennsylvania, United States, 18103
        • The Institute for Female Pelvic Medicine and Reconstructive Surgery
    • Virginia
      • Falls Church, Virginia, United States, 22042
        • Inova Health System Foundation
      • Norfolk, Virginia, United States, 23501
        • Eastern Virginia Medical School

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

21 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Sampling Method

Non-Probability Sample

Study Population

Patients scheduled for pelvic floor surgery

Description

Inclusion Criteria:

  1. Subject is female of 21 years or older, and
  2. No prior pelvic floor surgery, and
  3. One of the following:

Normal pelvic floor conditions, or POP Stage I affecting one or more vaginal compartment, or POP Stage II affecting one or more vaginal compartment, or POP Stage III affecting one or more vaginal compartment, or POP Stage IV affecting one or more vaginal compartment

Exclusion Criteria:

  1. Active skin infection or ulceration within the vagina
  2. Presence of a vaginal septum;
  3. Active cancer of the colon, rectum wall, cervix, vaginal, uterus or bladder;
  4. Ongoing radiation therapy for pelvic cancer;
  5. Impacted stool;
  6. Significant pre-existing pelvic pain including levator ani syndrome, severe vaginismus or vulvadynia;
  7. Severe hemorrhoids;
  8. Significant circulatory or cardiac conditions that could cause excessive risk from the examination as determined by attending physician;
  9. Current pregnancy.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Pre/post pelvic floor surgery imaging

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Tissue elasticity change after the surgery measured as a gradient in tactile image. Unit of measure: mmHg/mm
Time Frame: pre-surgery and post-surgery (4-6 months after surgery) measurements
Tissue elasticity is measured for entire anterior and posterior compartments
pre-surgery and post-surgery (4-6 months after surgery) measurements
Pelvic floor muscle strength change after the surgery measured as a pressure dynamic feedback during muscle contractions. Unit of measure: mmHg
Time Frame: pre-surgery and post-surgery (4-6 months after surgery) measurements
Muscle strength is measured during voluntary and involuntary muscle contractions, involuntary relaxation and Valsalva maneuver.
pre-surgery and post-surgery (4-6 months after surgery) measurements

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 1, 2016

Primary Completion (Actual)

December 1, 2018

Study Completion (Actual)

December 1, 2018

Study Registration Dates

First Submitted

October 3, 2016

First Submitted That Met QC Criteria

October 4, 2016

First Posted (Estimate)

October 6, 2016

Study Record Updates

Last Update Posted (Actual)

March 21, 2019

Last Update Submitted That Met QC Criteria

March 20, 2019

Last Verified

March 1, 2019

More Information

Terms related to this study

Other Study ID Numbers

  • VTI09
  • SB1AG034714 (U.S. NIH Grant/Contract)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

Scientific Publications of the study results

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe